Alex Arrow
Equibles does not estimate personal net worth.
About Alex Arrow
Earlier roles on record: CFO at Protagenic Therapeutics, Inc.\new (PTIX) until April 30, 2026. Protagenic Therapeutics, Inc.\new reported in an 8-K filed April 7, 2026 that Alex Arrow was terminated as Chief Financial Officer, effective April 30, 2026.
“On March 31, 2026, the Board of Directors of Protagenic Therapeutics, Inc. (the "Company") notified Alexander Arrow, MD, the Company's Chief Financial Officer, that his employment with the Company will be terminated effective April 30, 2026.”
Affiliation history
-
Start not stated–2026-04-30